Thursday, March 01, 2018 6:26:46 PM
Since Amarantus has always been a penny stock and the OTCBB, I'd say that the value of MANF has not been that much.
Now, if it can prove itself in clinical trials, then the value of it should go up tremendously.
But the problem remains on how Geraldo will be able to get it through clinical trials considering he has an abysmal record of getting anything done in a competent fashion.
I've said it before and I'll say it again, Geraldo should put his ego in check and have someone else run the company, someone who knows how to run a start up biotech. Obvious, he won't due to said inflated ego the fact he has to earn an income.
So don't be surprised when this comes crashing down again due to the incompetency of Geraldo Conusallagain.
Maybacks Global Entertainment and Lingerie Fighting Championships Enter Into Broadcast And Revenue Sharing Agreement • AHRO • Sep 26, 2024 8:30 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM